What is the differential diagnosis for a 27-year-old woman with a pulmonary mass and elevated serum beta‑human chorionic gonadotropin (β‑hCG)?

Differential Diagnosis: Pulmonary Mass with Elevated β-hCG in a 27-Year-Old Woman

The differential diagnosis must prioritize gestational trophoblastic neoplasia (GTN) with pulmonary metastases as the most likely and immediately life-threatening diagnosis, followed by primary pulmonary choriocarcinoma, germ cell tumors, and paraneoplastic β-hCG secretion from lung adenocarcinoma.

Primary Differential Considerations

1. Gestational Trophoblastic Neoplasia (GTN) with Pulmonary Metastases (Most Common)

This is the most critical diagnosis to rule out first given the patient's age and sex 1, 2, 3. GTN includes:

• Invasive mole
• Choriocarcinoma (most aggressive)
• Placental site trophoblastic tumor
• Epithelioid trophoblastic tumor

Key clinical features:

• History of recent pregnancy, miscarriage, abortion, or hydatidiform mole (within months to years) 2, 4, 5
• Markedly elevated β-hCG levels (often >100,000 mIU/mL in metastatic disease) 3, 5
• Pulmonary metastases are the most common site of distant spread 2, 3
• Can present with hemoptysis, dyspnea, chest pain 5
• May have concurrent metastases to other organs (kidney, brain, liver, heart) 4, 3

Critical pitfall: GTN can occur months to years after any gestational event, including normal pregnancies 4. Even a history of abortion 6 months prior is relevant 5.

2. Primary Pulmonary Choriocarcinoma (Rare but Important)

An extremely rare entity that must be distinguished from metastatic GTN 6, 5:

Distinguishing features:

• No history of recent pregnancy or gestational event
• Genetic testing shows XX chromosomes (confirms non-gestational origin) 5
• Requires exclusion of primary gonadal/uterine malignancies 6, 5
• Highly vascular tumors with risk of life-threatening hemorrhage 5
• Very poor prognosis compared to gestational choriocarcinoma

3. Epithelioid Trophoblastic Tumor (ETT)

A distinct subtype of GTN that can present as primary lung mass 7:

• Associated with irregular vaginal bleeding 7
• Elevated but often lower β-hCG levels compared to choriocarcinoma
• May occur years after gestational event
• Surgery is the primary treatment for localized disease 7

4. Germ Cell Tumors

Must be considered in young women with pulmonary masses and elevated β-hCG:

• Ovarian dysgerminoma or mixed germ cell tumor with pulmonary metastases
• Requires pelvic imaging and additional tumor markers (AFP, LDH) 1
• Check for primary ovarian mass

5. Paraneoplastic β-hCG Secretion from Lung Adenocarcinoma

Occurs in 12-24% of non-small cell lung cancers but usually at much lower levels 8, 9, 10:

Distinguishing features:

• β-hCG levels typically much lower (usually <1,000 mIU/mL) 8, 9
• More common in older patients with smoking history 8, 9
• Recent case showed EGFR mutation with elevated β-hCG 10
• Immunohistochemistry shows β-hCG staining in adenocarcinoma cells 8

Diagnostic Algorithm

Immediate Workup (Priority Order):

1. Detailed obstetric/gynecologic history:

   • Any pregnancy, miscarriage, abortion, or molar pregnancy in past 2 years
   • Recent menstrual history and contraception use
   • Vaginal bleeding patterns 7

2. Quantitative serum β-hCG level:

   • >100,000 mIU/mL strongly suggests GTN 3, 5
   • Lower levels (50-5,000 mIU/mL) may indicate paraneoplastic secretion 8, 9
   • Serial measurements track disease activity 1

3. Exclude false-positive β-hCG 1:

   • Check urine β-hCG (negative urine with positive serum suggests assay interference)
   • Rule out exogenous hCG use
   • Consider heterophile antibodies

4. Comprehensive imaging:

   • Pelvic ultrasound to identify uterine/ovarian primary tumor 1
   • CT chest/abdomen/pelvis for metastatic disease staging
   • Brain MRI if β-hCG >100,000 or neurologic symptoms (brain metastases common in high-risk GTN)
   • Consider FDG-PET-CT if primary site unclear 1

5. Additional tumor markers 1:

   • AFP and LDH (for germ cell tumors)
   • Renal function (elevated β-hCG can occur in renal failure)
   • FSH/LH (to exclude pituitary hCG in perimenopausal women)

6. Tissue diagnosis considerations:

   • GTN often diagnosed without biopsy if clinical picture and β-hCG levels are diagnostic 3
   • Biopsy is dangerous in highly vascular choriocarcinoma (risk of life-threatening hemorrhage) 5
   • If biopsy performed: immunohistochemistry for β-hCG, cytokeratin, and genetic testing (XX vs XY chromosomes) 6, 5

Critical Management Considerations

If GTN is suspected (most likely scenario):

• Do NOT delay treatment for tissue diagnosis if clinical picture is consistent 3
• Refer immediately to GTD center for risk stratification and chemotherapy 1
• High-risk metastatic GTN requires multiagent chemotherapy (EMA-CO regimen) 1
• Excellent prognosis with appropriate treatment (>90% cure rate) 2, 4
• Fertility preservation is possible 4

If primary pulmonary choriocarcinoma suspected:

• Requires genetic confirmation (XX chromosomes) 5
• Consider selective arterial embolization before any intervention due to hemorrhage risk 5
• Combined surgery and chemotherapy approach 6, 5
• Much worse prognosis than gestational GTN

Common pitfalls to avoid:

• Assuming negative pregnancy test rules out GTN (can be negative in metastatic disease) 5
• Performing biopsy on highly vascular lesions without embolization 5
• Missing occult pregnancy or recent gestational event in history 4
• Attributing elevated β-hCG solely to lung cancer without excluding GTN first 8, 9